← Eichor
Condition: Papillomaviridae Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Papillomaviridae

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NA · 2 location(s) · First Hospital of China Medical University · NCT07565350HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06550531Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HS
Phase 2 · 5 location(s) · Frantz Viral Therapeutics, LLC · NCT06075264The Organ Transplant Recipient HPV and Skin Cancer Study
Phase N/A · 3 location(s) · Merete Haedersdal · NCT05284877ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
NA · 1 location(s) · University of Florida · NCT06535139Reducing Urban Cervical Cancer Disparities
NA · 3 location(s) · Fox Chase Cancer Center · NCT06416150Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Phase 2 · 7 location(s) · Frantz Viral Therapeutics, LLC · NCT04098744Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
Phase 1/Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06007092Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07087145The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
NA · 1 location(s) · Ufuk University · NCT07320157Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatmen
Phase 4 · 18 location(s) · Labo'Life · NCT03977753Provider Recommendation and HPV Vaccination
NA · 1 location(s) · Kaiser Permanente · NCT05365048Natural History Study of GATA2 Deficiency and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01905826Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT05911750Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294HUC-MSC for Treatment of High-risk HPV Infection
Phase 1/Phase 2 · 1 location(s) · Shanghai East Hospital · NCT06610773Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06434337Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
NA · 1 location(s) · First Hospital of China Medical University · NCT07534865The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunoco
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01011712Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NA · 1 location(s) · First Hospital of China Medical University · NCT06827938Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Co
Phase N/A · 1 location(s) · Mayo Clinic · NCT06115772Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide C
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06821243Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05985681"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06587243Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for
NA · 2 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT06507917Stories to Prevent (StoP) HPV Cancers
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT06808776Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk
NA · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT06052033A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
NA · 1 location(s) · Emory University · NCT07104240
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.